Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of a Non-Invasive 13CO2 'Breath Test' to Detect Anabolic Resistance Following Step Reduction in Younger and Older Adults

NCT05216809 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT05216809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05216809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of a Non-Invasive 13CO2 'Breath Test' to Detect Anabolic Resistance Following Step Reduction in Younger and Older Adults
Lead sponsor
University of Toronto
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2022
Completion date
March 31, 2024
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, amino acids, dietary protein, sarcopenia, sedentary behavior